The Company holds an Virtual Investor Event in conjunction with the American College of Cardiology/World Heart Federation to discuss MK-0616 and Sotatercept on March 6 at 7 pm. Webcast Link
Published first on TheFly
See the top stocks recommended by analysts >>
Read More on MRK:
- Illumina and Myriad Genetics partner for HRD testing in the U.S.
- AstraZeneca says FDA to convene AdCom meeting on sNDA for Lynparza in mCRPC
- BeyondSpring enrolls first patient in study of Plinabulin, Keytruda, Docetaxel
- Merck says Phase 3 KEYNOTE-671 trial met one of dual primary endpoints
- NGM Biopharmaceuticals reports Q4 EPS (45c), consensus (51c)